tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF

Sumitomo Dainippon Pharma Co (DNPUF) Revenue

Compare
8 Followers

Sumitomo Dainippon Pharma Co Revenue

Sumitomo Dainippon Pharma Co had a revenue of 112.43B in the quarter ending Dec 31, 2024, with 24.82%. This bring the company's revenue in the last twelve months to 372.71B, Decreased 8.77%. In the fiscal year ending Mar 31, 2024, Sumitomo Dainippon Pharma Co had annual revenue of 314.56B with -43.38% growth.
Revenue (ttm)
372.71B
Revenue Growth
P/S Ratio
<0.01
Revenue/Employee
$63,164,257
Employees
4,980
Market Cap
$2.30B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2024
314.56B-240.99B-43.38%
Mar 31, 2023
555.54B-4.49B-0.80%
Mar 31, 2022
560.03B44.08B+8.54%
Mar 31, 2021
515.95B33.22B+6.88%
Mar 31, 2020
482.73B23.46B+5.11%
Mar 31, 2019
459.27B-7.57B-1.62%
Mar 31, 2018
466.84B55.19B+13.41%
Mar 31, 2017
411.64B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis